Pharma

Companies will have access to real-world patient data for clinical decision-making and research support, including hypothesis testing and cohort analysis.

Novo Nordisk is bringing its expertise in chronic disease management to Kakao's mobile diabetes app.

The company utilizes machine learning and patient data to deliver personalized medication management pertaining to polypharmacy.

It signed a distribution deal with UE LifeSciences to scale the access to iBreastExam in primary care clinics. 

The round brings the company's total raise to $93 million.

Naomi Fried, founder and CEO of PharmStars, discusses the 13 startups from its spring cohort and its call for applications for its fall 2023 cohort, Digital Innovations in Therapeutic Delivery: Supply Chain to the Patient Interface.

The CVS Health company's members will have access to GoodRx's generic drug prices through the new program, Caremark Cost Saver.

Posterity Health users will have access to medications through MCCPDC that help treat infertility, sexual dysfunction and low testosterone.

In a statement to MobiHealthNews, the cofounder of Mark Cuban Cost Plus Drug Company expressed excitement over the deal to offer the discounted Humira alternative.

The partners will develop a database for academics and biopharma researchers to acquire insights to help advance cancer-focused research.